Atrion CEO Emile Battat talks to The Wall Street Transcript.Business/Technology Editors NEW YORK--(BUSINESS WIRE)--July 17, 2000 The Wall Street Transcript A generic term for any kind of copy, particularly an official or certified representation of the record of what took place in a court during a trial or other legal proceeding. A transcript of record has published an in-depth interview with Emile Battat, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Atrion (Nasdaq:ATRI), in which he talks at length about the company's future. The entire 2,100-word interview is available free online at http://www.twst.com/ceos.htm Battat gives an overview of his company, "We are a manufacturing company with capabilities in engineering, design, assembly and packaging. Our basic processes in manufacturing involve plastic injection molding injection molding n. A manufacturing process for forming objects, as of plastic or metal, by heating the molding material to a fluid state and injecting it into a mold. , sonic son·ic adj. Of, relating to, or determined by audible sound. and RF welding welding, process for joining separate pieces of metal in a continuous metallic bond. Cold-pressure welding is accomplished by the application of high pressure at room temperature; forge welding (forging) is done by means of hammering, with the addition of heat. , solvent solvent, constituent of a solution that acts as a dissolving agent. In solutions of solids or gases in a liquid, the liquid is the solvent. In all other solutions (i.e. bonding, and electronic assembly. We produce high precision plastic parts, valves and other components that go primarily to the medical industry. Our valves also have significant applications in life vests for airline and marine uses. The company is also engaged in the development and marketing of its own patented medical devices for cardiovascular and ophthalmic ophthalmic /oph·thal·mic/ (of-thal´mik) ocular (1). oph·thal·mic adj. Of or relating to the eye; ocular. Ophthalmic Pertaining to the eye. applications." Battat explains, "I would like Atrion to be the number one or number two leader in key and growing segments of the medical device and product market. On our own, if we continue to execute well, we believe we have the potential to double our earnings within three years. We also believe that even faster growth is possible if we are able to adapt our MPS technology to new but related applications and to market this product internationally." Looking forward, Battat states, "In Atrion we have an unusual small company with an interesting mix of established and developmental products. We believe our market leadership position in several segments gives us a strong earnings base with solid growth prospects. Our newer products and devices bring excitement to our portfolio. Our stock price increased 33% last year and is ahead by a further 10% so far this year." This interview is part of a 110-page Drug & Medical Supply Distributors Issue available at http://www.twst.com/info/info132.htm or by calling (212) 952-7433 The Wall Street Transcript is a premier weekly investment publication serving serious long-term investors Long-term investor A person who makes investments for a period of at least five years in order to finance his or her long-term goals. for over 37 years. The Wall Street Transcript has launched a new free service where investors can ask Atrion (or any public company) a question at http://www.qawire.com The Wall Street Transcript does not endorse the views of any interviewees nor does it make stock recommendations. For subscription information call (800) 246-7673. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion